Skip to main content

Articles

Page 25 of 28

  1. Authors: Franziska Werner, Katharina Völker, Claus-Jürgen Scholz, Margarethe Goebel, Michael Seimetz, Baktybek Kojonazarov, Kai Schuh, Bhola K Dahal, Ralph T Schermuly, Heike Oberwinkler, Birgit Gaßner and Michaela Kuhn
    Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P77

    This article is part of a Supplement: Volume 14 Supplement 1

  2. Authors: Roland Seifert, Christina Hartwig, Sabine Wolter, Daniel Reinecke, Heike Burhenne, Volkhard Kaever, Antje Munder, Burkhard Tümmler, Frank Schwede, Manuel Grundmann, Evi Kostenis, Dara W Frank and Ulrike Beckert
    Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O36

    This article is part of a Supplement: Volume 14 Supplement 1

  3. Authors: Wen Chen, Heike Oberwinkler, Franziska Werner, Birgit Gaßner, Hitoshi Nakagawa, Robert Feil, Franz Hofmann, Jens Schlossmann, Alexander Dietrich, Thomas Gudermann, Motohiro Nishida, Sabrina Del Galdo, Thomas Wieland and Michaela Kuhn
    Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O35

    This article is part of a Supplement: Volume 14 Supplement 1

  4. Authors: Michaela Kuhn, Thomas Premsler, Ruey-Bing Yang, Thomas D Mueller, Birgit Gaßner, Heike Oberwinkler, Sabine E Hannema, Hermine A van Duyvenvoorde, Ferdinand Roelfsema, Gijs WE Santen, Timothy Prickett, Sarina G Kant, Annemieke JMH Verkerk, André G Uitterlinden, Eric Espiner, Claudia AL Ruivenkamp…
    Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P35

    This article is part of a Supplement: Volume 14 Supplement 1

  5. Authors: Sabine Klein, Barbara Seidler, Anna Kettenberger, Andrei Sibaev, Robert Feil, Franz Hofmann, Jean-Marie Vanderwinden, Hans-Dieter Allescher, Michael Schemann, Martin A Storr, Roland M Schmid, Günter Schneider and Dieter Saur
    Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P34

    This article is part of a Supplement: Volume 14 Supplement 1

  6. Authors: Sabine Klein, Barbara Seidler, Anna Kettenberger, Andrei Sibaev, Michael Rohn, Robert Feil, Hans-Dieter Allescher, Jean-Marie Vanderwinden, Franz Hofmann, Michael Schemann, Roland Rad, Martin A Storr, Roland M Schmid, Günter Schneider and Dieter Saur
    Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O30

    This article is part of a Supplement: Volume 14 Supplement 1

  7. Authors: Gilbert Y Huang, Jeong J Kim, Albert S Reger, Robin Lorenz, Eui-Whan Moon, Chi Zhao, Darren E Casteel, Daniela Bertinetti, Bryan VanSchouwen, Rajeevan Selvaratnam, James W Pflugrath, Banumathi Sankaran, Giuseppe Melacini, Friedrich W Herberg and Choel Kim
    Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O16

    This article is part of a Supplement: Volume 14 Supplement 1

  8. Authors: Pankaj Arora, Connie Wu, Donald B Bloch, Brandi N Davis-Dusenbury, Ester Spagnolli, Akiko Hata, Sara Vandenwijngaert, Melissa Swinnen, Stefan Janssens, Emmanuel S Buys, Kenneth D Bloch, Christopher Newton-Cheh and Thomas J Wang
    Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O10

    This article is part of a Supplement: Volume 14 Supplement 1

  9. Authors: Valentina Cannone, Paul M McKie, Angelo Baldassare Cefalu, Davide Noto, Giovanni Cavera, Michele Pagano, Michelangelo Sapienza, Timothy M Olson, Denise M Heublein, Christopher G Scott, Kent R Bailey, Maurizio Averna and John C Burnett Jr
    Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O7

    This article is part of a Supplement: Volume 14 Supplement 1

  10. There are many reports of cognitive dysfunction in patients receiving chemotherapy or targeted therapies. Many antineoplastic agents may be involved in the condition also known as “chemo brain” or “chemo fog”.

    Authors: Adeline Rollin-Sillaire, Xavier Delbeuck, Marianne Pollet, Marie-Anne Mackowiak, Pierre Lenfant, Marie-Pierre Noel, Thierry Facon, Xavier Leleu, Florence Pasquier and Emilie Le Rhun
    Citation: BMC Pharmacology and Toxicology 2013 14:41
  11. Anakinra pharmacokinetics and pharmacodynamics were investigated in children and adolescents treated for systemic-onset juvenile idiopathic arthritis (SJIA) and autoinflammatory syndromes.

    Authors: Saik Urien, Christophe Bardin, Brigitte Bader-Meunier, Richard Mouy, Sandrine Compeyrot-Lacassagne, Franz Foissac, Benoît Florkin, Carine Wouters, Bénédicte Neven, Jean-Marc Treluyer and Pierre Quartier
    Citation: BMC Pharmacology and Toxicology 2013 14:40
  12. The aim of this study was to assess the association between prescription changes frequency (PCF) and hospital admissions and to compare the PCF to the Chronic Disease Score (CDS). The CDS measures comorbidity ...

    Authors: Carolien GM Sino, Rutger Stuffken, Eibert R Heerdink, Marieke J Schuurmans, Patrick C Souverein and Toine (A) CG Egberts
    Citation: BMC Pharmacology and Toxicology 2013 14:39
  13. Olanzapine use has been reported during pregnancy and breastfeeding, but there are no controlled clinical trials assessing the safety of olanzapine exposure to infants and fetuses. The purpose of this report w...

    Authors: Elizabeth Brunner, Deborah M Falk, Meghan Jones, Debashish K Dey and Chetan Chinmaya Shatapathy
    Citation: BMC Pharmacology and Toxicology 2013 14:38
  14. The γ-aminobutyric acid (GABA) type A receptor (GABAAR) contains the recognition sites for a variety of agents used in the treatment of brain disorders, including anxiety and epilepsy. A better understanding of h...

    Authors: Shamol Saha, Yinghui Hu, Stella C Martin, Sabita Bandyopadhyay, Shelley J Russek and David H Farb
    Citation: BMC Pharmacology and Toxicology 2013 14:37
  15. Casein kinase 2 (CK2) is involved in various cellular events such as proliferation, apoptosis, and the cell cycle. CK2 overexpression is associated with multiple human cancers and may therefore be a promising ...

    Authors: Shu Liu, David Hsieh, Yi-Lin Yang, Zhidong Xu, Csaba Peto, David M Jablons and Liang You
    Citation: BMC Pharmacology and Toxicology 2013 14:36
  16. Amphetamine and amphetamine derivatives are suggested to induce an immunosuppressive effect. However, knowledge of how amphetamines modulate intracellular signaling pathways in cells of the immune system is li...

    Authors: Therese Bredholt, Elisabeth Ersvær, Bjarte Skoe Erikstein, André Sulen, Håkon Reikvam, Hans Jørgen Aarstad, Anne Christine Johannessen, Olav Karsten Vintermyr, Øystein Bruserud and Bjørn Tore Gjertsen
    Citation: BMC Pharmacology and Toxicology 2013 14:35
  17. The use of substandard and degraded medicines is a major public health problem in developing countries such as Cambodia. A collaborative study was conducted to evaluate the quality of amoxicillin–clavulanic ac...

    Authors: Mohiuddin Hussain Khan, Kirara Hatanaka, Tey Sovannarith, Nam Nivanna, Lidia Cecilia Cadena Casas, Naoko Yoshida, Hirohito Tsuboi, Tsuyoshi Tanimoto and Kazuko Kimura
    Citation: BMC Pharmacology and Toxicology 2013 14:33
  18. Dormant cells are characterised by low RNA synthesis. In contrast, cancer cells can be addicted to high RNA synthesis, including synthesis of survival molecules. We hypothesised that dormant cancer cells, alre...

    Authors: Monica Pallis, Francis Burrows, Abigail Whittall, Nicholas Boddy, Claire Seedhouse and Nigel Russell
    Citation: BMC Pharmacology and Toxicology 2013 14:32
  19. Protein-Protein Interactions (PPIs) are key for many cellular processes. The characterization of PPI interfaces and the prediction of putative ligand binding sites and hot spot residues are essential to design...

    Authors: Adriana Isvoran, Dana Craciun, Virginie Martiny, Olivier Sperandio and Maria A Miteva
    Citation: BMC Pharmacology and Toxicology 2013 14:31
  20. Infectious diseases are major public health problem. It is increasingly affecting more than 50 million people worldwide. Targeting shikimate pathway could be efficiently used for the development of broad spect...

    Authors: Prabakaran Pitchandi, Waheeta Hopper and Rathankar Rao
    Citation: BMC Pharmacology and Toxicology 2013 14:29
  21. The role of G protein-coupled receptor (GPR40), which is highly expressed in pancreatic beta cells, has been studied extensively in the amelioration of beta cell dysfunction in T2D using rat and mouse islets, ...

    Authors: Nagesh Gowda, Anilkumar Dandu, Jaideep Singh, Sanghamitra Biswas, Vijaya Raghav, Mudigere N Lakshmi, Pavagada C Shilpa, Venkategowda Sunil, Ashokkumar Reddy, Manojkumar Sadasivuni, Kumaraswamy Aparna, Mahesh Kumar Verma, Yoganand Moolemath, Mammen O Anup, Marikunte V Venkataranganna, Baggavalli P Somesh…
    Citation: BMC Pharmacology and Toxicology 2013 14:28
  22. Remogliflozin etabonate (RE) is the prodrug of remogliflozin, a selective inhibitor of the renal sodium-dependent glucose transporter 2 (SGLT2), which could increase urine glucose excretion (UGE) and lower pla...

    Authors: Anita Kapur, Robin O’Connor-Semmes, Elizabeth K Hussey, Robert L Dobbins, Wenli Tao, Marcus Hompesch, Glenn A Smith, Joseph W Polli, Charles D James Jr, Imao Mikoshiba and Derek J Nunez
    Citation: BMC Pharmacology and Toxicology 2013 14:26
  23. Rifampicin remains one of the first-line drugs used in tuberculosis therapy. This drug´s potential to induce the hepatic cytochrome P450 oxidative enzyme system increases the risk of drug-drug interactions. Th...

    Authors: Maria AP Martins, Adriano MM Reis, Mariana F Sales, Vandack Nobre, Daniel D Ribeiro, Manoel OC Rocha and Antônio LP Ribeiro
    Citation: BMC Pharmacology and Toxicology 2013 14:27
Reviewer acknowledgments

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 2.8
    5-year Journal Impact Factor: 2.7
    Source Normalized Impact per Paper (SNIP): 0.774
    SCImago Journal Rank (SJR): 0.710

    Speed 2024
    Submission to first editorial decision (median days): 15
    Submission to acceptance (median days): 130

    Usage 2024
    Downloads: 786,626
    Altmetric mentions: 260

Peer-review Terminology

  • The following summary describes the peer review process for this journal:

    Identity transparency: Single anonymized

    Reviewer interacts with: Editor

    Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication

    More information is available here

Sign up for article alerts and news from this journal